Last year highlighted significant developments with CRISPR-based therapies.
Last year highlighted significant developments with CRISPR-based therapies. The discovery of the CRISPR-Cas9 gene editing tool brought a revolutionary wave of treatment development for genetic disorders such as Duchenne Muscular Dystrophy, thalassemia and hemochromatosis.